statistical software medcalc version 9.6 (MedCalc Software Ltd)
90
Structured Review
MedCalc Software Ltd
statistical software medcalc version 9.6
Statistical Software Medcalc Version 9.6, supplied by MedCalc Software Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/statistical+software+version+9%2E6/medcalc+9+0+1/pmc11082670-155-12-17
Average 90 stars, based on 1 article reviews
Statistical Software Medcalc Version 9.6, supplied by MedCalc Software Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/statistical+software+version+9%2E6/medcalc+9+0+1/pmc11082670-155-12-17
Average 90 stars, based on 1 article reviews
statistical software medcalc version 9.6 - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
other:Article Title: Impact of Mutational Testing on the Diagnosis and Management of Patients with Cytologically Indeterminate Thyroid Nodules: A Prospective Analysis of 1056 FNA Samples Article Snippet: Calculations of specificity, sensitivity, positive predictive value, and negative predictive value were performed using Article Title: Next-Generation Sequencing Enhances the Diagnosis Efficiency in Thyroid Nodules Article Snippet: The calculation of analytical accuracy, limits of detection, and assay reproducibility was performed using Article Title: Two-miRNA classifiers differentiate mutation-negative follicular thyroid carcinomas and follicular thyroid adenomas in fine needle aspirations with high specificity. Article Snippet: Diagnosis of thyroid by fine needle aspiration is challenging for the “indeterminate” category and can be supported by molecular testing.. We set out to identify miRNA markers that could be used in a diagnostic setting to improve the discrimination of mutation-negative indeterminate fine needle aspirations. miRNA high-throughput sequencing was performed for freshly frozen tissue samples of 19 RAS and PAX8/PPARG mutation-negative follicular thyroid carcinomas, and 23 RAS and PAX8/PPARG mutation-negative follicular adenomas.. Differentially expressed miRNAs were validated by quantitative polymerase chain reaction in a set of 44 fine needle aspiration samples representing 24 follicular thyroid carcinomas and 20 follicular adenomas. |